MANCHESTER, England — Even when C-reactive protein (CRP) levels are normal, patients with seropositive rheumatoid arthritis (RA) could still be experiencing significant disease that persists over time ...

In their paper, Bogaty and colleagues write that considerable intraindividual variability in CRP levels has been found in healthy individuals, but it was unknown whether such variability extended to ...

In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.

Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health screenings.